Public health systems depend on reliable medicine supply, and the institutions that buy in volume — ministries of health, public and private hospitals, United Nations agencies and non-governmental organizations — need partners who can deliver against demanding specifications. GNH USA is a US-based, WHO GDP-certified pharmaceutical distributor serving institutional and government buyers worldwide. We source branded, generic, orphan and hard-to-find medicines from regulator-approved markets, prepare the documentation that tenders and procurement frameworks require, and move product through validated, traceable supply chains.
Who we serve
Built for institutional and government procurement
Ministries of health
We support national and regional health authorities sourcing essential and specialized medicines, including products that may be in short supply through local channels.
Hospitals and institutions
Public and private hospitals, hospital groups and large clinics rely on us for consistent supply of formulary and non-formulary medicines.
UN agencies and NGOs
United Nations bodies, international organizations and NGOs running treatment and relief programs need dependable, documented supply at scale.
Tender support
We help compile the technical and commercial documentation institutional tenders and bids commonly call for, aligned to each buyer's requirements.
WHO GDP-certified
Procurement and handling follow Good Distribution Practice, supporting product integrity and quality from the source market to delivery.
Cold-chain capability
Temperature-sensitive products, including biologics and vaccines, move through monitored, validated cold-chain lanes designed to protect them end to end.
Why it matters
Quality, documentation and traceability
WHO prequalification relevance
Many government and donor-funded programs reference WHO prequalification or comparable stringent-regulator approval when evaluating medicines and suppliers. We work to source products from regulator-approved markets and to provide documentation that supports these procurement criteria.
Tender-ready documentation
Tenders and framework contracts typically require certificates of analysis, batch and manufacturing details, regulatory status, GDP evidence and supply commitments. We assemble these to match the specification of each opportunity.
End-to-end traceability
From the source market through customs and onward delivery, shipments are documented so that batch and chain-of-custody information is available for audit, recall readiness and pharmacovigilance.
Validated cold chain
For products that must stay within a defined temperature range, we use monitored, validated lanes and provide temperature records so buyers can confirm the product arrived within specification.
Worldwide sourcing reach
As a US-based distributor with global supplier relationships, we can locate medicines that are unavailable, discontinued or in shortage in a given country, and supply them where they are needed.
Scale and continuity
Institutional programs need predictable, repeatable supply. We plan volume requirements and lead times so that ongoing programs are not interrupted.
The process
From tender or enquiry to delivery
- Step 01
Tender or enquiry
A ministry, hospital, UN agency or NGO shares the medicines required, quantities, delivery destinations and the tender or procurement specification.
- Step 02
Sourcing
We identify suitable regulator-approved source markets and confirm availability, pricing and lead times against the requirement.
- Step 03
Documentation and QA
We compile the technical and regulatory documentation the tender calls for and apply quality checks before shipment is confirmed.
- Step 04
Logistics
Product is prepared and shipped through GDP-compliant, traceable logistics, with validated cold-chain handling where required.
- Step 05
Delivery
Goods are delivered to the agreed destinations with full shipment and batch documentation for the buyer's records and audit.
Start a request
Invite a quote or share a tender
How we engage with institutional buyers
GNH USA supports governments, hospitals, UN agencies and NGOs as a sourcing and supply partner. Procurement rules, eligibility and award decisions rest with the buying institution; our role is to source compliantly, document thoroughly and deliver reliably under WHO GDP.
Request a quote
Questions
Government and institutional supply — FAQs
FAQ
Frequently asked questions
Who can buy through GNH USA's institutional supply service?
We work with ministries of health and government health authorities, public and private hospitals and hospital groups, United Nations agencies, international organizations and NGOs. The common thread is structured, often volume-based procurement with defined documentation and quality requirements.
Can GNH USA respond to government tenders?
Yes. We support competitive tenders and framework agreements by compiling the technical and commercial documentation typically required and by confirming sourcing, pricing and lead times. Award decisions and eligibility rules remain with the procuring institution.
How does WHO prequalification relate to institutional procurement?
Many government and donor-funded programs reference WHO prequalification or stringent-regulator approval when evaluating products and suppliers. We work to source from regulator-approved markets and to provide documentation that supports these criteria, while the applicable standard is set by each buyer or program.
How do you handle cold-chain and temperature-sensitive medicines?
Temperature-sensitive products, including biologics and vaccines, move through monitored, validated cold-chain lanes. We provide temperature and shipment records so buyers can verify the product was handled within specification on arrival.
What documentation comes with an institutional shipment?
Depending on the requirement, this can include certificates of analysis, batch and manufacturing details, regulatory status, GDP evidence and delivery records. Documentation is assembled to match the tender or procurement specification and to support audit and traceability.
Where does GNH USA source medicines from?
GNH USA is US-based and sources from regulator-approved markets worldwide. This global reach lets us supply medicines that may be unavailable, discontinued or in shortage in a particular country, with all handling following WHO GDP.
Related
Other services
Comparator Sourcing for Clinical Trials
Reference-listed drug and active comparator supply for clinical trials worldwide — direct from manufacturer, with WHO GDP-compliant logistics.
Clinical Trials Supply
End-to-end IMP sourcing, kitting and depot-to-site logistics — GDP-compliant warehousing, manufacturer relationships and a full source-to-site audit trail.
Validated Cold Chain Shipment
WHO GDP-validated cold-chain shipping for biologics, vaccines and temperature-sensitive medicines — qualified boxes and en-route temperature monitoring.